News Headline Summary
Novo Nordisk (NOVOB DC) shares open down 16% after it was reported that US regulators dealt a major blow to co.'s hopes for its new long acting insulin Tresiba by demanding they conduct annual clinical test to assess potential heart risks...
Analysis details (09:03)
- On the other hand, Sanofi Aventis shares up almost 4% as a result.
11 Feb 2013 - 09:02
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
Teams of analysts covering equities, fixed income, FX, energy, and metals markets
Real-time scrolling news service with instant analysis
Daily and weekly pre-market research and calendars
Video updates covering near-term key risk events & primary trading themes
One-to-one chat with our expert analysts